Southampton Hospital Radio launches free app to reach more listeners
The volunteer-run station, which has been broadcasting for more than 70 years, will now be able to reach listeners beyond the hospital through the free app.
Listeners can tune in from anywhere, whether at home, in the community, or on the go.
Simon Carter, a presenter at Southampton Hospital Radio, said: "What I really love is that there's no need to log in - you just tap the app and you're instantly connected.
Abby Oakley behind the mic at Southampton Hospital Radio studio (Image: Southampton Hospital Radio) "It's quick, easy, and the sound quality is absolutely fantastic."
Previously, the station was available mainly through bedside TV units, limiting its reach to hospital patients.
The app now allows anyone to access live broadcasts, request songs and dedications, and view the full programme schedule.
Users can also enjoy exclusive hospital podcasts, presenter blogs, and updates on both station and hospital news.
READ MORE: Only Fools and Horses star to bring festive fun to Fareham Live panto
Aaron Jacobs, another presenter, said: "This app is so much more than just a new way to listen - it brings our healthcare community closer together.
"Whether you're a patient, or just stumbled across us, it offers an easy, instant connection to something familiar and comforting.
"By downloading it, you're not just tuning in - you're becoming part of a shared experience that supports and uplifts everyone within healthcare in Southampton."
For those in hospital, the app also offers live commentary of Southampton FC matches.
The station has been serving patients, families, and staff since 1952.
It broadcasts 24 hours a day from Normand House and is run entirely by volunteers.
Listeners can download the free app by visiting shradio.uk/app or by searching for "Southampton Hospital Radio" in their device's app store.
Southampton Hospital Radio is a member of the National Hospital Broadcasting Association and has received the Queen's Award for Voluntary Service.
The station describes itself as a "vital presence within the Southampton healthcare community," offering entertainment, information, and companionship to listeners across hospitals, care homes, hospices, and treatment centres.
The launch marks a significant step in expanding the charity's reach and impact, making its services more accessible to the wider community.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
27 minutes ago
- Forbes
Why All Eyes Should Be On Manchester When It Comes To Regional Innovation
The UK's innovation and industrial agendas have historically been shaped by successive Westminster Governments, often leaving the insight and contribution of some of the UK's regional powerhouses behind. The recent announcement that the Industrial Strategy Council will be headquartered in Manchester, however, signals a much-needed shift away from centralised control, to one that recognises the incredible industrial heritage of the regions and the innovation being driven across the UK today. Manchester has created the blueprint for regional innovation, one grounded in long-term collaboration. It's a model that other areas across the UK would do well to study and adopt. This approach has not only elevated Manchester's profile but also attracted significant national and international attention and investment. Crucially, the city isn't standing still. The Greater Manchester Combined Authority (GMCA) recently announced The Greater Manchester Strategy, a ten-year vision underpinned by seven delivery workstreams that will cement Greater Manchester as 'a thriving city region where everyone can live a good life'. This new plan builds on Manchester's proven formula and introduces seven delivery workstreams designed to strengthen integration of public, private and academic sector ecosystems, and investment in growth areas and R&D. On the topic of which, recently we've seen a rapid growth in AI with Manchester and Salford ranked top for AI-readiness outside of London. The city is also leading the charge in digital health, data infrastructure, cybersecurity and FinTech businesses – all of which also align with the new Industrial Strategy's pillars – and it's becoming common knowledge that Manchester has earned a reputation as a world-class hub for life sciences in recent years. Indeed, Manchester's Inward Investment Agency, MIDAS, recently launched a new life sciences prospectus showcasing the city region's position as one of the UK's most dynamic health innovation ecosystems. Produced by MIDAS and the Oxford Road Corridor – Manchester's knowledge quarter – with contributions from a collection of key regional stakeholders including Bruntwood SciTech - the prospectus highlights the city's position within the UK's £120bn growing life sciences market and showcases its regional strengths in data, genomics, oncology and real-world evidence clinical trials. Rather than a city playing catch up, Manchester is a city setting the pace. But what truly sets it apart isn't just the funding it's received or the institutions it hosts, it's that the city has never waited for permission. Build first, attract later Manchester's progress and success has been the result of decades-long collaboration and a united long-term vision between civic leaders, universities, property developers and industry, forming an innovation ecosystem that existed well before national attention followed. Take Manchester Science Park with our new Greenheys development at its heart. The site is set to become home to UK Biobank, the world's most significant source of data and biological samples for health research. UK Biobank being a part of Manchester's already thriving ecosystem has been instrumental in securing the £20 million being awarded through the Industrial Strategy, supporting its delivery of the world's most significant protein study. With the data made accessible to approved researchers worldwide, the project exemplifies how locally driven success stories can attract major government backing and deliver global scientific value. The timing is also significant. The NHS's new 10-year plan announced at the beginning of July places renewed emphasis on data-driven innovation, early diagnostics and partnership with industry. In Manchester, we're already seeing how strong relationships between Manchester University NHS Foundation Trust, the Oxford Road Corridor and joint ventures like Bruntwood SciTech can deliver on this vision. The co-location of life science businesses alongside NHS clinicians and researchers offers a powerful draw for tech, innovation and science businesses looking to scale in a real-world healthcare setting. By demonstrating ambition, clarity and joined up thinking locally, Manchester has built something that national government is now backing. Local leadership, national returns Manchester may be the blueprint, but cities like Liverpool, Leeds, Birmingham and Glasgow are also carving distinct innovation paths that deserve greater attention and resourcing. Liverpool is expanding its Knowledge Quarter with a growing focus on infection research and digital health, powered by strong university partnerships and the proactive work of local leaders to create a globally recognised health and life sciences cluster. Meanwhile, Leeds has become a centre of excellence in med tech, Glasgow is establishing itself as a leader in quantum and photonics, and Birmingham is capitalising on its strengths in clean tech and advanced manufacturing, with innovation campuses like Tyseley Energy Park and Birmingham Health Innovation Campus. In each case, we see the same pattern: regional stakeholders identifying their unique assets, building coalitions across academia, industry and public services, and developing the spaces, strategies and talent pipelines to match. This groundwork doesn't wait for central government support, it earns it. If the UK wants to truly unlock the power of regional innovation, it must move beyond one-off funding packages and lean into long-term partnerships with local authorities, councils, metro mayors and institutions that have proven they can deliver. The takeaway then isn't that Manchester is better – it's that it was prepared. The city offers a case study in how others can align infrastructure, leadership and industry to create self-sustaining innovation economies. And when this is done well, it doesn't just lead to local success, it attracts national investment.
Yahoo
an hour ago
- Yahoo
At-home health tests have surged in popularity. But many are unclear and unreliable, UK report finds
A slew of at-home medical tests have flooded supermarkets, pharmacies, and wellness shops in recent years, claiming they can identify everything from gluten sensitivity to male fertility without the need for a doctor's visit. But most self-tests sold do not provide clear information about who should use them, how to interpret the results, or what to do next, according to a new pair . Many also contradict formal health guidance, which could be confusing and prompt people to make 'inappropriate' decisions about their health care, the researchers warned. 'We expect [a self-test] to be accurate and we expect it to be evidence-based if it's going to be sold to the general public,' Dr Alex Richter, one of the studies' authors and a professor of clinical immunology at the University of Birmingham, said during a press briefing. 'Unfortunately, we found that many tests gave unclear or at least missing guidance'. Related Promising results show new spit test could be better at detecting prostate cancer than blood test Independent experts said the results were alarming, particularly given the booming market for at-home tests, predicted to be valued at hundreds of millions of euros by 2030. But with the abundance of choice, it can be difficult for consumers to pick out high-quality tests from the pack. For the new reports, Richter's team examined 30 self-tests for 19 health issues, including vitamin D deficiency, menopause, blood sugar levels, HIV, bowel cancer, and prostate health. Only 14 tests made statements about their accuracy, eight offered information on the box about who should or should not use the test, and seven told consumers what they should do after taking the test. Sixteen tests explicitly said they were for screening, diagnosis, or monitoring, while another nine did not provide information about the symptoms or risk factors for their use. Nearly all of the tests recommended following up with a doctor if the results were positive or abnormal, the studies found. Two dozen tests claimed they were highly accurate, but the evidence to back up those assertions was either of poor quality or not publicly available, prompting the researchers to raise ethical concerns. Two companies – Newfoundland and Suresign – had the most problematic tests, the research found. They make rapid tests for menopause, vitamin D deficiency, the diagnosis of chronic kidney injury, and to detect thyroid problems. Independent experts said the results should serve as a reminder that at-home tests can be useful, but they should not replace traditional, evidence-based medical care. Related Exclusive: At-home spit test that measures hormone levels is now certified as a contraceptive 'Sometimes people use self-tests because they 'feel it is better to know' and they are trying to inform their health and healthcare decisions,' Dr Amitava Banerjee, a cardiologist and professor of clinical data science at University College London, said in a statement. 'This research shows that these self-tests are often not providing relevant knowledge or information and they are not informing decisions in the right way,' added Banerjee, who was not involved with the studies. The study authors called for more regulation of self-tests, saying they should be thoroughly evaluated before reaching the supermarket or pharmacy shelves to protect consumers and the healthcare system from 'misuse and misinformation'. Richter said the findings should not cause people to cast doubt on all self-tests. At-home pregnancy tests, for example, have been available for many years and are highly reliable when used correctly. And during the COVID-19 pandemic, self-tests were a cheaper, faster way for people to identify infections, easing some of the burden on the health system. 'We think there is a real place for this. … We just need to work out how they can be properly used and assessed,' Richter said. 'We don't want bad tests on the market, we want good tests on the market'.
Medscape
an hour ago
- Medscape
Food Allergies Tied to Increased Mental Health Risk in Kids
TOPLINE: Food allergies in children were associated with elevated risks for eating disorders, anxiety, and depression. These mental health risks varied from those seen in children with other chronic conditions such as asthma, atopic dermatitis, and type 1 diabetes. METHODOLOGY: Researchers conducted a retrospective study including data from 1,153,984 children aged 0-18 years from UK primary care practices between 2000 and 2021 to assess the link between food allergies and mental health outcomes. The participants were categorized into those with food allergies (n = 23,263; median age, 5 years; 43% girls); without food allergies (n = 1,130,721; median age, 8 years; 48% girls); and with asthma (n = 136,453; median age, 8 years; 43% girls), type 1 diabetes (n = 4835; median age, 11 years; 45% girls), or atopic dermatitis (n = 207,575; median age, 5 years; 51% girls) with no history of food allergies. All participants were followed up for at least 1 year and up to 20 years to assess the development of specified mental health conditions. TAKEAWAY: Children with food allergies had significantly higher risks of being diagnosed with eating disorders (adjusted hazard ratio [aHR], 1.85; 95% CI, 1.42-2.41), anxiety (aHR, 1.35; 95% CI, 1.25-1.45), and depression (aHR, 1.24; 95% CI, 1.11-1.39) than children without food allergies. Children with food allergies had a significantly lower risk for depression than their peers with asthma (aHR, 0.77; 95% CI, 0.68-0.87) and those with type 1 diabetes (aHR, 0.64; 95% CI, 0.54-0.76). The risk for anxiety was significantly lower among children with food allergies than among those with asthma (aHR, 0.86; 95% CI, 0.79-0.91). IN PRACTICE: 'In light of these results, we recommend a holistic approach to FA [food allergy] management that integrates mental health screening and support into routine care,' the authors wrote. 'This could involve regular psychological assessments, educational programs about potential mental health risks for patients and families, and closer collaboration between allergists and mental health professionals,' they added. SOURCE: Natalie Flaks‑Manov, with KI Research Institute, Kfar Malal, Israel, was the lead author of the study, which was published online on July 16 in the European Journal of Pediatrics. LIMITATIONS: The study was potentially limited by its retrospective design and reliance on routine electronic health record data, lacking confirmation of mental health diagnoses by specialists or use of standardized tools. Additionally, data on both the severity of various conditions and family history of mental illness were missing. DISCLOSURES: The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
